Joanne M. Donovan's most recent trade in Edgewise Therapeutics Inc was a trade of 168,750 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Aug. 12, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2025 | 168,750 | 168,750 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2025 | 28,125 | 28,125 | - | - | Restricted Stock Units | |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 5,781 | 28,223 | - | 0 | Common Stock | |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Aug 2025 | 5,781 | 17,344 | - | - | Restricted Stock Units | |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Sale of securities on an exchange or to another person at price $ 13.39 per share. | 12 Aug 2025 | 2,862 | 25,361 | - | 13.4 | 38,329 | Common Stock |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 10,417 | 0 | - | - | Restricted Stock Units | |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2025 | 10,417 | 26,775 | - | 0 | Common Stock | |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Sale of securities on an exchange or to another person at price $ 16.45 per share. | 01 May 2025 | 5,187 | 21,588 | - | 16.5 | 85,348 | Common Stock |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.08 per share. | 28 Jan 2025 | 25,000 | 41,358 | - | 7.1 | 177,000 | Common Stock |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Sale of securities on an exchange or to another person at price $ 27.63 per share. | 28 Jan 2025 | 25,000 | 16,358 | - | 27.6 | 690,658 | Common Stock |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2025 | 25,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Sale of securities on an exchange or to another person at price $ 28.29 per share. | 20 Sep 2024 | 7,162 | 14,538 | - | 28.3 | 202,603 | Common Stock |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 138,750 | 138,750 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 23,125 | 23,125 | - | - | Restricted Stock Units | |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 10,417 | 10,417 | - | - | Restricted Stock Units | |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2024 | 10,417 | 23,579 | - | 0 | Common Stock | |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Sale of securities on an exchange or to another person at price $ 18.91 per share. | 01 May 2024 | 3,682 | 19,897 | - | 18.9 | 69,627 | Common Stock |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 10,416 | 13,214 | - | 0 | Common Stock | |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 10,416 | 20,834 | - | - | Restricted Stock Units | |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Sale of securities on an exchange or to another person at price $ 8.91 per share. | 01 May 2023 | 3,254 | 9,960 | - | 8.9 | 28,977 | Common Stock |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2022 | 240,000 | 240,000 | - | - | Stock Option (Right to Buy) | |
| Edgewise Therapeutics Inc | Joanne M. Donovan | CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2022 | 31,250 | 31,250 | - | - | Restricted Stock Units |